Xeris Biopharma Holdings (XERS) Tax Provisions (2022 - 2024)
Xeris Biopharma Holdings' (XERS) quarterly Tax Provisions came in at -$3.3 million in Q3 2024, down 883.43% YoY from $424287.0 in Q4 2023, and down 543.79% on a QoQ basis from $749000.0 in Q2 2024.
Xeris Biopharma Holdings (XERS) Tax Provisions (2022 - 2024) Analysis & Trends
Xeris Biopharma Holdings (XERS) has 3 years of Tax Provisions data on file, last reported at -$3.3 million in Q3 2024.
- Quarterly Tax Provisions fell 883.43% year-over-year to -$3.3 million in Q3 2024, while the trailing twelve-month figure through Jun 2025 was -$3.3 million (down 789.63% YoY) and the FY2024 annual result came in at -$2.3 million, down 81.59% from the prior year.
- Tax Provisions eased to -$3.3 million in Q3 2024, from $749000.0 in the prior quarter.
- In the past five years, Tax Provisions ranged from a high of $749000.0 in Q2 2024 to a low of -$3.3 million in Q3 2024.
- A 3-year average of -$494100.0 and a median of -$338500.0 in 2022 frame the typical range for Tax Provisions.
- The widest YoY moves for Tax Provisions: up 210.96% in 2024, down 883.43% in 2024.
- Tracing XERS's Tax Provisions over 3 years: stood at -$338000.0 in 2022, then surged by 30.18% to -$236000.0 in 2023, then plunged by 1308.47% to -$3.3 million in 2024.
- The last three Tax Provisions figures came in at -$3.3 million (Q3 2024), $749000.0 (Q2 2024), and $307000.0 (Q1 2024), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.07 Bn | 43.10 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.41 Bn | 39.75 Bn | 2.15 Bn | 121.00 Mn |
| 3 | Zoetis | 31.83 Bn | 30.15 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.77 Bn | 22.97 Bn | 5.10 Bn | -310.32 Mn |
| 5 | United Therapeutics | 22.27 Bn | 19.61 Bn | 683.80 Mn | 39.70 Mn |
| 6 | Viatris | 18.76 Bn | 17.87 Bn | 1.46 Bn | 54.80 Mn |
| 7 | Neurocrine Biosciences | 15.65 Bn | 15.26 Bn | 935.80 Mn | 17.80 Mn |
| 8 | Elanco Animal Health | 11.93 Bn | 11.40 Bn | 798.00 Mn | 2.00 Mn |
| 9 | Dr Reddys Laboratories | 10.16 Bn | 10.00 Bn | - | - |
| 10 | Xeris Biopharma Holdings | 1.50 Bn | 1.37 Bn | 79.59 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2024 | -3.32 Mn |
| Jun 30, 2024 | 749,000.00 |
| Mar 31, 2024 | 307,000.00 |
| Dec 31, 2023 | -236,000.00 |
| Sep 30, 2023 | -338,000.00 |
| Jun 30, 2023 | -675,000.00 |
| Dec 31, 2022 | -338,000.00 |
| Sep 30, 2022 | -339,000.00 |
| Jun 30, 2022 | -339,000.00 |
| Mar 31, 2022 | -408,000.00 |